Abstract
Our results provide evidence that novel candidate genes for autism may be differentially expressed in lymphoid cell lines from individuals with autism spectrum disorders. This finding further suggests the possibility of developing a molecular screen for autism based on expressed biomarkers in peripheral blood lymphocytes, an easily accessible tissue. In addition, gene networks are identified that may play a role in the pathophysiology of autism.
Introduction
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by social communication deficits and repetitive behaviors. Diagnosis currently relies on behavioral assessments, often occurring after critical early intervention windows. While highly heritable, identifying definitive genetic biomarkers is complicated by the disorder's multigenic nature and the scarcity of live brain tissue for study. This research investigates whether peripheral blood-derived cells can serve as a molecular proxy for neurological dysregulation in the brain.
Methods
The study utilized a monozygotic (MZ) twin design to control for genetic background, treating twins as "nature’s perfect control." Five pairs of MZ twins were analyzed: three discordant for a classic autism diagnosis and two concordant for autism but differing significantly in language impairment severity. Lymphoblastoid Cell Lines (LCLs) derived from these individuals were profiled using DNA microarrays containing nearly 40,000 human cDNA elements. Differentially expressed genes were identified via Significance Analysis of Microarrays (SAM) and mapped into functional biological networks using Ingenuity Pathways Analysis (IPA). Findings were validated using quantitative RT-PCR (qPCR).
Results and Key Insights
The analysis identified approximately 1,200 genes with significantly altered expression across the twin sets. A striking finding was the enrichment of genes involved in nervous system development and function, despite these being immune-derived cells. This suggests a significant "blood-brain connection" where peripheral tissues mirror neurological processes.
Key validated genes included ASS (involved in nitric oxide production), DAPK1 (associated with apoptosis), and ROBO1 (critical for axon guidance). Notably, 50-55% of the identified genes mapped to chromosomal regions previously linked to autism susceptibility in large-scale genomic studies.
Discussion: Inflammatory Hubs and Clinical Severity
The differentially expressed genes were not randomly distributed but clustered into functional networks. A primary network was centered on Tumor Necrosis Factor (TNF) and other inflammatory mediators, supporting the hypothesis that neuroinflammation plays a central role in ASD pathophysiology.
Furthermore, the degree of gene expression change often correlated with the severity of clinical symptoms, such as language impairment. The researchers also found a significant decrease in the expression of the serotonin transporter (5-HTT) in more severely affected twins, providing a molecular link to the long-observed phenomenon of hyperserotonemia in some autistic individuals.
Conclusion
While limited by a small sample size, this study demonstrates that LCLs from MZ twins can reveal distinct molecular signatures of autism. These findings suggest that easily accessible peripheral tissues could one day be used for earlier, more objective ASD diagnostics and highlight the importance of inflammatory and neurological pathways in the disorder's development.
Summary updated